Why Choose the Evidence Series?
- Biochip technology is proven to produce high quality, accurate and precise test results with CVs typically <10%.
- Multiplex testing of up to 49 parameters at once from a single patient sample reduces time, labour and costs associated with individual tests.
- Multiple sample types can be used including serum, plasma, whole blood, urine and oral fluid delivering unrivalled flexibility.
- Multiplex testing allows for complete patient profiling ultimately enabling clinicians to make well informed decisions and accurate diagnosis.
- With a range of semi-automated and automated analysers, the Evidence series offers true versatility to meet the demands of all laboratory throughputs.
- Our diverse test menu comprises routine and novel markers for a variety of applications such as immunoassay, forensic toxicology, research and food diagnostics.
In 2002, Randox invented a world first, Biochip Technology, instantly changing the landscape of diagnostic testing forever. Biochip Technology is a multiplex platform which provides an unrivalled increase in patient information per sample. Instead of a patient sample needing to be subdivided for each test result, or in some cases re-collected, Biochip Technology offers a complete diagnostic patient profile with each patient sample. So now the patient’s needs become the focus, as Randox Biochips deliver the multiple results needed for improved diagnosis.
With over £250 million invested into research and development, Randox have launched a range of Biochip immunoanalysers – The Evidence Series. This includes the Evidence, the Evidence+, Investigator, MultiSTAT and Evolution. Each analyser is developed with boundary pushing engineering, designed to deliver financial, labour and time savings for the end user. Utilising patented Biochip technology, the Evidence Series guarantees cost-effective, highly accurate and flexible testing solutions.
Choose from the Randox Evidence, Evidence+, Investigator, MultiSTAT or Evolution to begin your Biochip journey today!
Click on the analysers below for more information
Evidence MultiSTAT
Fast, Fully Automated, Versatile
Evidence Investigator
Adaptable, Efficient & Comprehensive
Evidence+
Faster Testing, Accurate Results
Evidence
World’s 1st Biochip Technology Analyser
Evidence Evolution
Versatile, Quality & Efficiency
The World’s only Biochip Technology Immunoassay Test Menu
| Acute Kidney Injury | |||
| Clusterin | Cystatin C | Kidney Injury Molecule-I | Lipocalin |
| Adhesion Molecules | |||
| E-Selectin | Intercellular Adhesion Molecule-I | L-selectin | P-selectin |
| Vascular Cell Adhesion Molecule-I | |||
| Anaemia | |||
| Ferritin | |||
| Alzheimers Risk | |||
| ApoE4 | Pan ApoE | ||
| Cerebral | |||
| D-Dimer | Neuron Specific Enolase | Neutrophil Gelatinase-Associated Lipocalin | Soluble Tumour Necrosis Factor Receptor I |
| Chronic Kidney Disease | |||
| C3a Des Arg | C-Reactive Protein | Cystatin C | D-Dimer |
| Epidermal Growth Factor | Fatty Acid-Binding Protein I | Interlukin-8 | Macrophage Inflammatory Protein-1α |
| Neutrophil Gelatinase-Associated Lipocalin | Soluble Tumour Necrosis Factor Receptor I | Soluble Tumour Necrosis Factor Receptor II | |
| Covid-19 | |||
| SARS-CoV-2 Antigen | Receptor Binding Domain | Nucleocapsid | |
| Cytokines | |||
| Granulocyte-Macrophage Colony Stimulating Factor | Interleukin-1α | Interleukin-1ϐ | Interleukin - 2 |
| Interleukin - 3 | Interleukin - 4 | Interleukin - 5 | Interleukin - 6 |
| Interleukin - 7 | Interleukin - 8 | Interleukin - 10 | Interleukin - 12p70 |
| Interleukin - 13 | Interleukin - 15 | Interleukin - 23 | Interferon Gamma |
| Human EGF | Monocyte Chemotactic Protein | Macrophage Inflammatory Protein-1α | Matrix Metalloproteinase-9 |
| Soluble IL-2 Receptor α | Soluble IL-6 Receptor | Soluble Tumour Necrosis Factor Receptor I | Soluble Tumour Necrosis Factor Receptor II |
| Tumour Necrosis Factor Alpha | Vascular Endothelial Growth Factor |
| Epidermal Growth Factor (EGF) | |||
| Amphiregulin (AREG) | Herapin-Binding EGF-like Growth Factor (HBEGF) | Transforming Growth Factor - Alpha (TGF-α) | |
| Gastrointestinal | |||
| Gastrin 17 | Helicobacter Pylori | Pepsinogen I | Pepsinogen II |
| Immunodeficiency | |||
| Interleukin - 17A | Interleukin - 17F | Interleukin - 22 | Interleukin - 17 |
| Metabolic | |||
| Ferritin | Interleukin - 6 | Insulin | Adiponectin |
| C-Reactive Protein | Cystatin C | Leptin | Parathyroid Hormone |
| Plasminogen Activator Inhibitor-I | PTH | Resistin | Tumour Necrosis Factor α |
| Pancreatic Cancer | |||
| Cancer Antigen 19-9 - CA19-9 | Carcinoembryonic Antigen | Alpha-I-Acid Glycoprotein | |
| Stroke | |||
| Brain-Derived Neurotrophic Factor - BDNF | D-Dimer | Glial Fibrillary Acidic Protein - GFAP | Glutathione S - Transferase Pi - GSTPi |
| Heart-Type Fatty Acid-Binding Protein - FABP3 | Interleukin-6 - IL-6 | Nucleoside Diphosphate Kinase - NDKA | Neuron Specific Enolase - NSE |
| Parkinson Protein 7 - PARK-7 | Soluble Tumour Necrosis Factor Receptor I - sTNFRI |
| Thyroid | |||
| Anti-Thyroglobulin (TgAb) | Anti-Thyroid Peroxidase Antibody (TPOAb) | Thyroxine Binding Globulin (TBG) | Total Thyroxine (TT4) |
| Total Tri-Iodothyronine (TT3) | |||
| Tissue Damage | |||
| Adipose Fatty Acid Binding Protein - FABP4 | Brain Fatty Acid Binding Protein - FABP7 | Epidermal Fatty Acid Binding Protein - FABP5 | Heart-Type Fatty Acid-Binding Protein - FABP3 |
| Ileal Fatty Acid Binding Protein - FABP6 | Liver Fatty Acid Binding Protein-I - FABPI | Testis Fatty Acid Binding Protein - FABP9 |
| DoA I+ | |||
| Amphetamine | Barbiturates | Benzodiazepines I (Oxazepam) | Benzodiazepines II (Lorazepam) |
| Buprenorphine | Benzoylecgonine (Cocaine Metabolite) | Cannabinoids (THC) | Creatinine (Urine Only) |
| Methadone | Methamphetamine | MDMA | Opiate |
| Phencyclidine (PCP) | Tricyclic Antidepressants (TCA) | ||
| DoA ULTRA | |||
| Amphetamine | Barbiturates | Benzodiazepines I (Oxazepam) | Benzodiazepines II (Lorazepam) |
| Benzodiazepines III (Clonazepam) | Benzoylecgonine (Cocaine Metabolite) | Buprenorphine | Cannabinoids (THC) |
| Dextromethorphan | Fentanyl | Generic Opioids | Meprobamate |
| Methadone | Methamphetamine | Opiates | Oxycodone I |
| Oxycodone II | Phencyclidine (PCP) | Tramadol | Tricyclic Antidepressants (TCA) |
| Zolpidem | |||
| DoA Hair Array | |||
| Amphetamine | Benzodiazepine | Cannabinoids (THC) | Benzoylecgonine (Cocaine Metabolite) |
| Hydrocodone | Ketamine | Methamphetamine | Opiate |
| Oxymorphone | Phencyclidine (PCP) | ||
| DoA MultiSTAT - Blood | |||
| α-PVP (Flakka) | Amphetamine | Barbiturates | Benzodiazepines |
| Benzoylecgonine (Cocaine Metabolite) | Buprenorphine | Cannabinoids (THC) | Ethyl Glucuronide (EtG) |
| Fentanyl | Methadone | Methamphetamine | Opiate |
| Oxycodone | Phencyclidine (PCP) | Pregabalin | Synthetic Cannabinoids (AB-CHMINACA) |
| Synthetic Cannabinoids (AB-PINACA) | Tramadol | Tricyclic Antidepressants (TCA) | 6-MAM |
| DoA MultiSTAT - Oral Fluid | |||
| α-PVP (Flakka) | Amphetamine | Barbiturates | Benzodiazepines I (Oxazepam) |
| Benzodiazepines II (Lorazepam) | Benzoylecgonine (Cocaine Metabolite) | Buprenorphine | Cannabinoids (THC) |
| Fentanyl | LSD | Methadone | Methamphetamine |
| Opiate | Oxycodone | Phencyclidine (PCP) | Synthetic Cannabinoids (JWH-018) |
| Synthetic Cannabinoids (UR-144/XLR-11) | Tramadol | 6-MAM | Ketamine |
| DoA MultiSTAT - Urine I | |||
| α-PVP (Flakka) | Amphetamine | Barbiturates | Benzodiazepines I (Oxazepam) |
| Benzodiazepines II (Lorazepam) | Benzoylecgonine (Cocaine Metabolite) | Buprenorphine | Cannabinoids (THC) |
| Creatinine | Ethyl Glucuronide (EtG) | Fentanyl | Methadone |
| Methamphetamine | Opiate | Oxycodone | Synthetic Cannabinoids (JWH-018) |
| Synthetic Cannabinoids (UR-144/XLR-11) | Synthetic Cannabinoids (AB-PINACA) | Tramadol | Tricyclic Antidepressants (TCA) |
| 6-MAM | |||
| DoA MultiSTAT - Urine II | |||
| Alpha-PVP | AB-PINACA | AB-CHMINACA | Amphetamine |
| Barbiturate | Benzodiazepine | BZG | Creatinine |
| Cannabinoids (THC) | Ethyl Glucuronide | Fentanyl | Methamphetamine |
| Methadone | Opiate | PCP | Pregabalin |
| Synthetic Cannabinoids (UR-144) | Tricyclic Antidepressants | Tramadol | 6-MAM |
| ToxPlex MultiSTAT | |||
| Acetaminophen | Amphetamine | Barbiturates | Buprenorphine |
| Benzoylecgonine (BZG) | Cannabinoids (THC) | Clonazepam | Creatinine (Urine Only) |
| Dextromethorphan | Ethyl Glucuronide (EtG) | Fentanyl | Haloperidol |
| Ketamine | MDMA | Meprobamate | Methadone |
| Methamphetamine | Methaqualone | Opiate | Oxazepam |
| Oxycodone | Phencyclidine (PCP) | Pregabalin | Propoxyphene |
| Salicylate | Tramadol | Tricyclic Antidepressants (TCA) | Zolpidem |
| 6-MAM | Xylazine (Blood Only) |
| NPS I | |||
| AB-CHMINACA (Synthetic Cannabinoids) | AB-PINACA (Synthetic Cannabinoids) | Bath Salts I (Mephedrone / Methcathinone) | Bath Salts II (α-PVP / MDPV) |
| Benzylpiperazines | JWH-018 (Synthetic Cannabinoids) | Mescaline | Phenylpiperazines I |
| Phenylpiperazines II | Salvinorin | UR-144/XLR-11 (Synthetic Cannabinoids) | |
| NPS II | |||
| Acetylfentanyl | AH-7921 | Buprenorphine | Carfentanil/Remifentanil |
| Clonazepam | Etizolam | Furanylfentanyl | Mitragynine |
| MT-45 | Naloxone | Ocfentanyl | Sufentanil |
| U-47700 | W-19 |
| CARDIAC RISK PREDICTION | |||
| Target | SNP | Target | SNP |
| MIA3* | rs17465637 | LPA* | rs3798220 |
| 9p21 | rs10757274 | LPA* | rs10455872 |
| DAB2IP | rs7025486 | MRAS* | rs9818870 |
| CXCL12 | rs1746048 | LPL* | rs328 |
| ACE | rs4341 | LPL | rs1801177 |
| NOS3 | rs1799983 | SORT1*+ | rs646776+ |
| APOA5 | rs662799 | PCSK9 | rs11591147 |
| SMAD3 | rs17228212 | APOE* | rs429358 |
| APOB* | rs1042031 | APOE* | rs7412 |
| CETP | rs708272 | ||
| CHRONIC LUNG DISEASE (CLD) ARRAY | |||
| Viral | |||
| Adenovirus | Metapneumovirus | Respiratory syncytial virus A | Respiratory syncytial virus B |
| Rhinovirus A/B/C | Influenza virus A | Influenza virus B | |
| Bacterial | |||
| Achromobacter xylosoxidans | Bordetella pertussis | Burkholderia cepacia complex (21spp) | Burkholderia cenocepacia |
| Chlamydia pneumoniae | Haemophilus influenza | Moraxella catarrhalis | Mycoplasma pneumoniae |
| Non-tuberculous mycobacterium (15 spp) | Mycobacterium avium complex (4 spp) | Pandoraea species (5 spp) | Prevotella species (16 spp) |
| Pseudomonas aeruginosa | Staphylococcus aureus | Stenotrophomonas maltophilia | Streptococcus pneumoniae (21 spp) |
| Streptococcus species (19 spp) | Veillonella species (3 spp) | ||
| Fungal | |||
| Aspergillus fumigatus | Candida albicans | Exophialia dermatitidis | Scedosporium species (7 spp) |
| Antibiotic Resistance Markers | |||
| mecA (incl MRSA) |
| FAMILIAL HYPERCHOLESTEROLEMIA | |||
| LDLR 38 mutations | APOB 1 mutation | PCSK9 1 mutation | |
| APOB | PCSK9 | ||
| Mutation | Protein | Mutation | Protein |
| c.10580G>A | p.(Arg3527Gln) | c.1120G>T | p.(Asp374Tyr) |
| LDR | |||
| Mutation | Protein | Mutation | Protein |
| c.2292delA | p.(Ile764Metfs*2) | c.1187-10G>A | p.(=) |
| c.1444G>A | p.(Asp482Asn) | c.1048C>T | p.(Arg350*) |
| c.551G>A | p.(Cys184Tyr) | c.118delA | p.(Ile40Serfs*166) |
| c.1845+11C>G | p.(=) | c.1168A>T | p.(Lys390*) |
| c.693C>A | p.(Cys231*) | c.232C>T | p.(Arg78Cys) |
| c.933delA | p.(Glu312Serfs*58) | c.1587-1G>A | p.(=) |
| c.301G>A | p.(Glu101Lys) | c.1706-10G>A | p.(=) |
| c.313+1G>A | p.(=) | c.1796T>C | p.(Leu599Ser) |
| c.1706-1G>A | p.(=) | c.1436T>C | p.(Leu479Pro) |
| c.1706-1G>A | p.(Cys677Arg) | c.1474G>A | p.(Asp492Asn) |
| c.2029T>C | p.(Pro685Leu) | c.501C>A | p.(Cys167*) |
| c.2054C>T | p.(Trp483Arg) | c.662A>G | p.(Asp221Giy) |
| c.1447T>C | p.(Gly478Arg) | c.682G>T | p.(Glu228*) |
| c.1447T>C | p.(Asp72Thrfs*134) | c.1150C>T | p.(Gln384*) |
| c.214delG | p.(Trp87Gly) | c.938G>A | p.(Cys313Tyr) |
| c.259T>G | p.(Arg633Cys) | c.136T>G | p.(Cys46Gly) |
| c.1897C>T | p.(Asp227Glu) | c.2042G>C | p.(Cys681Ser) |
| c.681C>G | p.(Asn688Glnfs*29) | c.1618G>A | p.(Ala540Thr) |
| c.1285G>A | p.(Val429Met) | c.680_681delAC | p.(Asp227Glyfs*12) |
| KRAS, BRAF, PIK3CA ARRAY | |||
| KRAS Gene Targets | |||
| G12A | G12R | G12D | G12C |
| G12S | G12V | G13D | G13C |
| G13R | Q61K | Q61L | Q61R |
| Q61H(1) | Q61H(2) | A146T | A146P |
| BRAF Gene Targets | |||
| V600EG12R | |||
| PIK3CA Gene Targets | |||
| E542K | E545K | H1047R | |
| RESPIRATORY MULTIPLEX ARRAY II | |||
| Viral | |||
| Influenza A | Influenza B | Adenovirus A/B/C/D/E | Bocavirus 1/2/3 |
| Coronavirus 229E/NL63 | Coronavirus OC43/HKUI | Enterovirus A/B/C | Metapneumovirus |
| Parainfluenza virus 1 | Parainfluenza virus 2 | Parainfluenza virus 3 | Parainfluenza virus 4 |
| Respiratory syncytial virus A/B | Rhinovirus A/B/C | ||
| Bacterial | |||
| Legionella pneumophila | Bordetella pertussis | Chlamydophila pneumoniae | Haemophilus influenzae |
| Moraxella catarrhalis | Mycoplasma pneumoniae | Streptococcus pneumoniae |
| SEXUALLY TRANSMITTED INFECTION (STI) ARRAY | |||
| Pathogens | |||
| Chlamydia trachomatis (CT) | Neisseria gonorrhoea (NG) | Trichomonas vanginalis (TV) | Mycoplasma genitalium (MG) |
| Treponema pallidum (Syphilis) (TP) | Herpes simplex virus 1 (HSV-1) | Herpes simplex virus 2 (HSV-2) | Haemophilus ducreyi (HD) |
| Mycoplasma hominis (MH) | Ureaplasma urealyticum (UU) | ||
| URINARY TRACT INFECTION (UTI) ARRAY | |||
| Bacterial | |||
| Acinetobacter baumannii | Citrobacter freundii | Citrobacter koseri | Klebsiella aerogenes |
| Enterobacter cloacae | Enterococcus faecalis | Enterococcus faecium | Escherichia coli |
| Klebsiella oxytoca | Klebsiella pneumoniae | Morganella morganii | Proteus spp. |
| Pseudomonas aeruginosa | Providencia rettgeri | Providencia stuartii | Serratia marcescens |
| Staphylococcus aureus | Staphylococcus epidermidis | Staphylococcus saprophyticus | Streptococcus agalactiae (GBS) |
| Fungal | |||
| Candida albicans | |||
| Antibiotic Resistance Markers | |||
| mecA (incl MRSA) | Trimethoprim Resistance 1 | Trimethoprim Resistance 2 | Trimethoprim Resistance 3 |
| S mecA (incl MRSA) | Trimethoprim Resistance 4 | Trimethoprim Resistance 5 | Van A (Vancomycin Resistance A) |
| Van B (Vancomycin Resistance B) |
| 17β-Clostebol | Cefquinome | Imidocarb | Penicillin V | Sulphamethoxazole |
| 5-hydroxy Flunixin | Ceftiofur | Kanamycin | Phenylbutazone | Sulphamethoxypyridazine |
| Aflatoxin B1/B2 | Cefuroxime | Lasalocid | Pirlimycin | Sulphamonomethoxine |
| Aflatoxin G1/G2 | Cephalexin | Levamisole | Polymixins | Sulphapyridine |
| Aflatoxin M1 | Cephalonium | Lincomycin | Quinolones | Sulphaquinoxaline |
| AHD | Cephapirin | Lincosamides | Ractopamine | Sulphathiazole |
| Amikacin/Kanamycin | Chloramphenicol | Maduramicin | Rifaximin | Sulphisoxazole |
| Amino Benzimidazoles | Chlormadinone | Melamine | Robenidine | Sulphonamides |
| Amino Benzimmidazoles | Clopdiol | Meloxicam | Salinomycin | T2 Toxin |
| Amoxicillin | Cloxacillin | Metamizole | SEM | Tetracyclines |
| AMOZ | Corticosteroids | Methylprednisolone | Spectinomycin | Thiabendazole |
| Amphenicols | Dapsone | Methyltestosterone | Spiramycin | Thiamphenicol |
| Ampicillin | Decoquinate | Monensin | Spiramycin/Josamycin | Tobramycin |
| AOZ | Deoxynivalenol | Moxidectin | Stanozolol | Tolfenamic Acid |
| Apramycin | Dexamethasone | Nafcillin | Stilbenes | Toltrazuril |
| Avermectins | Diacetoxyscirpenol | Nandrolone | Streptomycin | Trenbolone |
| Avermectins (Generic) | Diclazaril | Neomycin | Streptomycin/Dihydrostreptomycin | Triclabendazole |
| Bacitracin | Dicloxacillin | Neomycin/Paromomycin | Sulfaguanidine | Trimethoprim |
| Baquiloprim | Ergot Alkaloids | Nicarbazin | Sulfamethazine | Tylosin |
| Benzimidazoles | Erythromycin | Nitroimidazoles | Sulphachlorpyridazine | Tylosin B/Tilmicosin |
| Beta-Lactams | Ethinylestradiol | Nitroxynil | Sulphadiazine | Virginiamycin |
| Beta-Agonists | Fumonisins | Novobiocin | Sulphadimethoxine | Zearalenone |
| Boldenone | Gentamycin | Ochratoxin A | Sulphadoxine | Zeranol |
| Cefacetril | Gestagens | Oxacillin | Sulphamerazine | |
| Cefazolin | Halofuginone | Paxilline | Sulphamethazine | |
| Cefoperazone | Hygromycin B | Penicillin G | Sulphamethizole |
Product availability may vary from country to country. Some product may be for Research use Only. For more information on product application and availability, please contact your local Randox Representative.